Correlation Between Inhibrx and Star Equity
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Star Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Star Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Star Equity Holdings, you can compare the effects of market volatilities on Inhibrx and Star Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Star Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Star Equity.
Diversification Opportunities for Inhibrx and Star Equity
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Inhibrx and Star is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Star Equity Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Star Equity Holdings and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Star Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Star Equity Holdings has no effect on the direction of Inhibrx i.e., Inhibrx and Star Equity go up and down completely randomly.
Pair Corralation between Inhibrx and Star Equity
Given the investment horizon of 90 days Inhibrx is expected to generate 1.07 times more return on investment than Star Equity. However, Inhibrx is 1.07 times more volatile than Star Equity Holdings. It trades about -0.01 of its potential returns per unit of risk. Star Equity Holdings is currently generating about -0.38 per unit of risk. If you would invest 1,555 in Inhibrx on September 3, 2024 and sell it today you would lose (29.00) from holding Inhibrx or give up 1.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Star Equity Holdings
Performance |
| Timeline |
| Inhibrx |
| Star Equity Holdings |
Inhibrx and Star Equity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Star Equity
The main advantage of trading using opposite Inhibrx and Star Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Star Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Equity will offset losses from the drop in Star Equity's long position.| Inhibrx vs. DiaMedica Therapeutics | Inhibrx vs. Lyra Therapeutics | Inhibrx vs. Centessa Pharmaceuticals PLC |
| Star Equity vs. Volitionrx | Star Equity vs. Biodesix | Star Equity vs. Fonar | Star Equity vs. Burning Rock Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |